Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
300 participants
OBSERVATIONAL
2025-06-15
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations
NCT06935513
Wearable ECG for AF Screening and Stroke Risk Assessment
NCT06907264
Patient Status Engine (PSE): EARLY FEASIBILITY AND USABILITY STUDY
NCT03480204
Machine Learning-based Early Clinical Warning of High-risk Patients
NCT05410171
Smart Technology Facilitated Patient-centered Venous Thromboembolism Management
NCT06350344
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
This study is designed to assess the non-inferiority of a novel ultrasound imaging technique, rather than to evaluate a therapeutic intervention.
This study is designed to assess the non-inferiority of a novel ultrasound imaging technique, rather than to evaluate a therapeutic intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Relevant diagnosis for study arm (heart failure, lower-limb DVT, or ICU monitoring)
* Adequate acoustic window and intact skin at sensor site
Arm-specific:
* Heart-failure arm: Clinically stable HFrEF or HFpEF on standard therapy
* DVT arm: Imaging-confirmed lower-limb DVT, anticoagulated or scheduled for intervention
* ICU arm: ICU/post-op patient requiring continuous bedside ultrasound
Exclusion Criteria
* Local skin infection, open wound, or implant/hardware blocking sensor
* Inability to cooperate with monitoring
Arm-specific:
* Heart-failure arm: Acute MI or uncontrolled arrhythmia in past 3 months
* DVT arm: Active bleeding or severe coagulopathy
* ICU arm: Unstable multi-organ failure precluding safe monitoring
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese PLA General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yu-kun Luo
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yukun Luo, Professor, M.D.
Role: PRINCIPAL_INVESTIGATOR
Chinese PLA General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chinese PLA General Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S2025-096-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.